Alzamend Neuro, Inc. (ALZN)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.9346 |
| Open | 0.9300 |
| Bid | 0.9300 x 900 |
| Ask | 0.9500 x 4000 |
| Day's range | 0.9300 - 0.9500 |
| 52-week range | 0.8010 - 12.1400 |
| Volume | |
| Avg. volume | 853,033 |
| Market cap | 84.079M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.1030 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 11.25 |
- Business Wire
Alzamend Neuro to Present at the 12th Annual LD Micro Invitational
ATLANTA, June 03, 2022--Alzamend Neuro to Present at 12th Annual LD Micro Invitational Investor Conference; Focuses on Progress with Clinical Trials & INDs for AL001 & AL002
- Business Wire
Alzamend Neuro Announces Pre-IND Submission for AL001 as a Treatment of Bipolar Disorder, Major Depressive Disorder and Post-Traumatic Stress Disorder
ATLANTA, May 17, 2022--Alzamend Neuro Announces Pre-IND Submission for AL001 as a Treatment of Bipolar Disorder, Major Depressive Disorder and Post-Traumatic Stress Disorder
- Business Wire
Alzamend Neuro Announces Initiation of Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s
ATLANTA, May 05, 2022--Alzamend Neuro Announces Initiation of Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s
© 2022 Yahoo. All rights reserved.
